您当前的位置:有道健康网资讯正文

曹雪涛自己回复论文数据造假质疑称难辞其咎但对论文重复性充满信心

放大字体  缩小字体 2019-11-18 20:54:50  阅读:5240 作者:责任编辑NO。卢泓钢0469

刚刚,针对Elisabeth Bik发文质疑2008年宣布在Blood杂志上的文章数据,曹雪涛院士自己进行了回应:

Elisabeth Bik提出的质疑:

Figure 1A. The "unstimulated" and "LPS" panels in the BAPTA-AM row appear to look unexpectedly similar. Shown with red boxes. Could the authors please check?

以下为曹雪涛院士的回复:

Dear Dr. Bik,

I’m writing to you in response to recent inquiries you posted with regard to mentioned studies conducted at the National Key Laboratory of Medical Immunology and Institute of Immunology at the Second Military Medical University, with me being the corresponding author.

关于您最近宣布的关于在第二军医大学医学免疫学国家要点试验室和免疫学研讨所进行的上述研讨的问询,我写信给您,我是通讯作者。

I appreciate your interest in our work and your commitment to protecting the accuracy of scientific records and the integrity of research pursuit. They are of utmost importance to me all along as well. Upon being notified of your inquiries, I have made them our highest priority and immediately took steps to look into the concerns you raised with the team and collaborators and carefully re-examined our manuscripts and raw data and lab records.We’ll work with the relevant journal editorial office(s) immediately if our investigation indicates any risk to the highest degree of accuracy of the published records.(首要任务便是自查,假如有问题,就撤稿!)

感谢您对咱们作业的爱好以及您对维护科学记载的准确性和研讨寻求的完整性的许诺。一直以来,它们对我也至关重要。在收到您的问询后,我将其列为咱们的首要任务,并当即采纳办法查询您与团队和协作者提出的问题,并细心地从头查看了咱们的手稿,原始数据和试验室记载。假如咱们的查询显现所发布记载的最高准确性存在任何危险,咱们将当即与相关的期刊编辑部协作。

based on our analyses up to this point (still ongoing) and additional feedback we received from colleagues and peers, I would like to add that I remain confident about the validity and strength of the scientific conclusions made in those publications and our work’s reproducibility. Nevertheless, there is no excuse for any lapse in supervision or laboratory leadership and the concerns you raised serve as a fresh reminder to me just how important my role and responsibility are as mentor, supervisor, and lab leader; and how I might have fallen short. I feel therefore very heavy-hearted and tremendously sorry, to my current and former students, my staff and colleagues, my peers, and the larger community. I most sincerely apologize for any oversight on my part and any inconvenience it might have caused. I’ll use this as an invaluable learning opportunity to do better not only in advancing science, but also in safeguarding the accuracy and integrity of science.

依据到现在为止的剖析(仍在进行中)以及从搭档和同行那里取得的其他反应,我想弥补一点,我对这些出版物中得出的科学定论的有效性和优势以及咱们作业的可重复性依然充满信心。可是,监督或试验室领导地位的任何失调都是没有托言的,您提出的疑虑再次提示我,我作为指导者,主管和试验室领导者的人物和职责是多么重要;以及我或许无法做到的工作。因而,关于我现在和曾经的学生,我的职工和搭档,我的同龄人以及整个社区,我感到十分心情沉重,并感到十分抱愧。关于我的忽略以及给您带来的不方便,我深表抱歉。

Yours sincerely,

Xuetao Cao

在信中,曹雪涛院士表达了抱歉,特别指出,作为领导者难辞其咎。但一起也着重对试验的重复性充满信心

作为本乡培育的免疫学界标杆人物,无数人的偶像,曹雪涛院士及时回复质疑,直面问题,就事论事,我只能说,这比过往其他很多被质疑的“心虚教授”不知强多少...

可是作为科研数据的严谨性来说,此次事情也给曹雪涛院士团队敲响了警钟,高处不胜寒,作为标杆人物,任何一点瑕疵都会被扩大,即便对文章的数据可重复性胸中有数。

曹雪涛院士简介

曹雪涛院士1964年出生于山东省济南市,17岁就读于第二军医大学海医系本科,22岁在第二军医大学攻读硕士研讨生,26岁时硕士结业于第二军医大学。同在26岁时被颁发博士学位,28岁破格晋升为其时我国最年青的医学教授。32岁晋升为博士生导师,33岁担任三军免疫与基因治疗要点试验室主任,41岁成为其时最年青的中国工程院院士。此外,他仍是其时我国最年青的将军。现在是南开大学校长。

本文经授权转载自:弗雷赛斯

“如果发现本网站发布的资讯影响到您的版权,可以联系本站!同时欢迎来本站投稿!